CT
NVO

Caldwell Trust’s Novo Nordisk NVO Stock Holding History

Caldwell Trust’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.4K Sell
50
-170
-77% -$7.3K ﹤0.01% 760
2026
Q1 		$8.09K Hold
220
– – ﹤0.01% 679
2025
Q4 		$11.2K Sell
220
-1,447
-87% -$74K ﹤0.01% 642
2025
Q3 		$92.5K Sell
1,667
-12,010
-88% -$703K 0.01% 397
2025
Q2 		$944K Sell
13,677
-2,035
-13% -$138K 0.09% 167
2025
Q1 		$1.09M Buy
15,712
+188
+1% +$15.5K 0.12% 154
2024
Q4 		$1.34M Buy
15,524
+1,289
+9% +$139K 0.14% 131
2024
Q3 		$1.69M Buy
14,235
+6,816
+92% +$909K 0.18% 116
2024
Q2 		$1.06M Buy
7,419
+4,379
+144% +$580K 0.12% 142
2024
Q1 		$390K Buy
3,040
+2,940
+2,940% +$350K 0.05% 239
2023
Q4 		$10.3K Buy
+100
New +$9.89K ﹤0.01% 604

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Caldwell Trust's NVO Position: Q2 2026 in Review

Caldwell Trust reduced its Novo Nordisk (NVO) stake by 77% in Q2 2026, selling an estimated $7.3K and leaving 50 shares worth $2.4K. The position accounts for ﹤0.01% of the portfolio, ranked #760.

Caldwell Trust first reported a position in NVO in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.69M in Q3 2024. 1,356 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Caldwell Trust held 50 shares of Novo Nordisk worth $2.4K as of Q2 2026.
  • Caldwell Trust sold 170 Novo Nordisk shares in Q2 2026, an estimated $7.3K.
  • Novo Nordisk made up ﹤0.01% of Caldwell Trust's portfolio in Q2 2026, its #760 holding.
  • Caldwell Trust first reported a position in Novo Nordisk in Q4 2023 and has held it in 11 quarters since.
  • Caldwell Trust's Novo Nordisk position peaked at $1.69M in Q3 2024.
  • 1,356 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Caldwell Trust's 13F filing for Q2 2026, filed 3 Aug 2026.